BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8151381)

  • 1. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.
    Tamaki N; Takahashi N; Kawamoto M; Torizuka T; Tadamura E; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1994 Apr; 35(4):594-600. PubMed ID: 8151381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial perfusion tomography imaging in patients without prior myocardial infarction--comparison between 201Tl, 99mTc-tetrofosmin and dual-isotope protocol (rest 201Tl/stress 99mTc-tetrofosmin)].
    Kamínek M; Myslivecek M; Skvarilová M; Husák V; Lang O
    Vnitr Lek; 1999 Feb; 45(2):81-4. PubMed ID: 15641225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease.
    Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T
    J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.
    Nakajima K; Taki J; Shuke N; Bunko H; Takata S; Hisada K
    J Nucl Med; 1993 Sep; 34(9):1478-84. PubMed ID: 8355067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined rest thallium-201/stress technetium-99m-tetrofosmin SPECT: feasibility and diagnostic accuracy of a 90-minute protocol.
    Mahmood S; Gunning M; Bomanji JB; Gupta NK; Costa DC; Jarritt PH; Swanton H; Ell PJ
    J Nucl Med; 1995 Jun; 36(6):932-5. PubMed ID: 7769448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin.
    Takahashi N; Tamaki N; Tadamura E; Kawamoto M; Torizuka T; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J
    J Nucl Cardiol; 1994; 1(1):29-38. PubMed ID: 9420668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.
    Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M
    Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
    Zaret BL; Rigo P; Wackers FJ; Hendel RC; Braat SH; Iskandrian AS; Sridhara BS; Jain D; Itti R; Serafini AN
    Circulation; 1995 Jan; 91(2):313-9. PubMed ID: 7805233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 99Tcm-tetrofosmin myocardial perfusion scintigraphy in the assessment of patients with previous myocardial infarction: a comparative study with 201Tl.
    Burak Z; Akin H; Buket S; Sagcan A; Argon M; Atay Y; Durmaz I; Duman Y
    Nucl Med Commun; 1998 Feb; 19(2):127-36. PubMed ID: 9548196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
    Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
    J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
    J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease.
    Acampa W; Cuocolo A; Sullo P; Varrone A; Nicolai E; Pace L; Petretta M; Salvatore M
    J Nucl Cardiol; 1998; 5(3):265-74. PubMed ID: 9669581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.
    Cuocolo A; Nicolai E; Soricelli A; Pace L; Nappi A; Sullo P; Cardei S; Argenziano L; Ell PJ; Salvatore M
    J Nucl Cardiol; 1996; 3(3):194-203. PubMed ID: 8805739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease.
    Azzarelli S; Galassi AR; Foti R; Mammana C; Musumeci S; Giuffrida G; Tamburino C
    J Nucl Cardiol; 1999; 6(2):183-9. PubMed ID: 10327103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine coronary vasodilation in coronary artery disease: technetium-99m tetrofosmin myocardial tomography versus echocardiography.
    Cuocolo A; Sullo P; Pace L; Nappi A; Gisonni P; Nicolai E; Trimarco B; Salvatore M
    J Nucl Med; 1997 Jul; 38(7):1089-94. PubMed ID: 9225796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomographic myocardial imaging with technetium-99m tetrofosmin. Comparison with tetrofosmin and thallium planar imaging and with angiography.
    Benoit T; Vivegnis D; Lahiri A; Itti R; Braat S; Rigo P
    Eur Heart J; 1996 Apr; 17(4):635-42. PubMed ID: 8733099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
    Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
    J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.